Jeffrey Oram - 14 Jul 2021 Form 4 Insider Report for Alzamend Neuro, Inc. (ALZN)

Role
Director
Signature
/s/ Jeffrey Oram
Issuer symbol
ALZN
Transactions as of
14 Jul 2021
Transactions value $
$0
Form type
4
Date filed
16 Jul 2021, 17:00
Previous filing
14 Jun 2021
Next filing
15 Sep 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALZN Restricted Stock Grant Award $0 +100K $0.00 100K 15 Jun 2021 Common Stock 100K Direct F1, F2
transaction ALZN Stock Options (Right to Buy) Award $0 +300K $0.00 300K 15 Jun 2021 Common Stock 300K $2.50 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit is the economic equivalent of one share of Common Stock, par value $0.0001, of Alzamend Neuro, Inc.
F2 The restricted stock grant vest contemporaneously with the Options (as defined below).
F3 The stock options (the "Options") vest in 36 equal monthly installments commencing on September 13, 2021 and are exercisable upon vesting.